logo
Plus   Neg
Share
Email

Lilly : CHMP Issues Positive Opinion To Expand Trulicity Label

Eli Lilly and Co. (LLY) said that the European Medicines Agency's Committee for Medicinal Products for Human Use or CHMP issued a positive opinion recommending an update to the Trulicity or dulaglutide label and indication statement.

The committee agreed the label should include results from the REWIND cardiovascular outcomes trial, which achieved a significant 12 percent risk reduction in major adverse cardiovascular events or MACE.

The CHMP has recommended updating the Trulicity indication to reflect both glycemic control and the impact on cardiovascular events as fundamental considerations in a treatment for people with type 2 diabetes.

In addition, the updated label will reflect the consistent MACE risk reduction with Trulicity across major demographic and disease subgroups.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The United Auto Workers at General Motors will remain on strike until ratification of a new four-year labor contract, the union said on Thursday. GM's proposed agreement includes an $11,000 ratification bonus to workers, wage increases of 4 percent throughout the four-year contract, no increases in health care costs; and a path to permanent worker status within four years or less. Streaming giant Netflix Inc. (NFLX) announced that it secured rights to Jeff Smith's critically acclaimed comic book series BONE. Netflix said it plans to develop an animated kids series based on BONE that follows the iconic Bone cousins on an adventure through a vast, uncharted desert and into a... Swedish luxury auto maker Volvo Cars unveiled its first fully electric car, the XC40 Recharge. The XC40 Recharge is a part of the electrified car portfolio that Volvo plans to introduce under the new 'Recharge' sub-brand. The company said it plans to launch a fully electric car every year over the...
Follow RTT
>